TRIP11

Chr 14AR

thyroid hormone receptor interactor 11

Also known as: ACG1A, CEV14, GMAP-210, GMAP210, ODCD, ODCD1, TRIP-11, TRIP230

This gene was identified based on the interaction of its protein product with thyroid hormone receptor beta. This protein is associated with the Golgi apparatus. The N-terminal region of the protein binds Golgi membranes and the C-terminal region binds the minus ends of microtubules; thus, the protein is thought to play a role in assembly and maintenance of the Golgi ribbon structure around the centrosome. Mutations in this gene cause achondrogenesis type IA.[provided by RefSeq, Mar 2010]

Primary Disease Associations & Inheritance

Achondrogenesis, type IAMIM #200600
AR
Odontochondrodysplasia 1MIM #184260
AR
UniProtAchondrogenesis 1A
0
Active trials
7
Pathogenic / LP
76
ClinVar variants
3
Pubs (1 yr)
0.5
Missense Z
0.50
LOEUF
Clinical SummaryTRIP11
🧬
Gene-Disease Validity (ClinGen)
TRIP11-related skeletal dysplasia · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
7 Pathogenic / Likely Pathogenic· 46 VUS of 76 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.50LOEUF
pLI 0.000
Z-score 5.72
OE 0.39 (0.300.50)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
0.52Z-score
OE missense 0.95 (0.901.01)
903 obs / 947.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.39 (0.300.50)
00.351.4
Missense OE0.95 (0.901.01)
00.61.4
Synonymous OE1.06
01.21.6
LoF obs/exp: 39 / 101.1Missense obs/exp: 903 / 947.7Syn Z: -0.89
DN
DN
0.7033th %ile
GOF
0.4283th %ile
LOF
0.3162th %ile

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

76 submitted variants in ClinVar

Classification Summary

Pathogenic4
Likely Pathogenic3
VUS46
Likely Benign20
Benign2
Conflicting1
4
Pathogenic
3
Likely Pathogenic
46
VUS
20
Likely Benign
2
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
3
0
1
0
4
Likely Pathogenic
3
0
0
0
3
VUS
0
42
3
1
46
Likely Benign
0
1
7
12
20
Benign
0
0
1
1
2
Conflicting
1
Total643121476

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

TRIP11 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

TRIP11-related achondrogenesis

definitive
ARLoss Of FunctionAbsent Gene Product
Dev. DisordersSkeletal
G2P ↗

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Landmark / reviewRecent case evidence